We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VALN market cap is 300.79M. The company's latest EPS is EUR -1.4603 and P/E is -1.47.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 40.13M | 46.89M | 126.5M | 41.62M | 54.23M |
| Operating Income | -22.64M | -59.95M | 68.21M | -21.59M | -12.57M |
| Net Income | -34.23M | -32.16M | 58.91M | -24.93M | -9.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 137.71M | 129.62M | 371.72M | 376.84M | 175.73M |
| Operating Income | 855k | -55.24M | -61.35M | -113.4M | -82.07M |
| Net Income | -1.74M | -64.39M | -73.43M | -143.28M | -101.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 520.54M | 460.06M | 502.83M | 466.57M | 516.61M |
| Total Liabilities | 363.02M | 331.82M | 313.6M | 300.29M | 299.15M |
| Total Equity | 157.52M | 128.25M | 189.23M | 166.28M | 217.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 264.72M | 449.16M | 817.35M | 621.34M | 460.06M |
| Total Liabilities | 129.57M | 371.74M | 646.77M | 401.55M | 331.82M |
| Total Equity | 135.15M | 77.42M | 170.58M | 219.8M | 128.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -136.83M | -202.74M | -28.43M | -66.26M | -76.74M |
| Investing | -4.27M | -20.58M | 86.71M | 87.61M | 72.23M |
| Financing | 26.14M | 63.08M | -7.46M | -16.59M | 35.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 5.53M | 137.74M | 76.9M | -245.34M | -202.74M |
| Investing | -10.69M | -19.34M | -93.12M | -29.05M | -20.58M |
| Financing | -7.7M | 21.74M | 154.5M | 215.12M | 63.08M |
| Market Cap | 300.79M |
| Price to Earnings Ratio | -1.47 |
| Price to Sales Ratio | 0.85 |
| Price to Cash Ratio | 1.18 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 69.46M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.96 (42.59%) |
| Company Name | Valneva SE |
| Address |
6 rue alain bombard saint-herblain, loire-atlantique 44800 |
| Website | https://www.valneva.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
